0001209191-21-043883.txt : 20210629
0001209191-21-043883.hdr.sgml : 20210629
20210629213108
ACCESSION NUMBER: 0001209191-21-043883
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210629
FILED AS OF DATE: 20210629
DATE AS OF CHANGE: 20210629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEW ENTERPRISE ASSOCIATES 10 L P
CENTRAL INDEX KEY: 0001132326
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40545
FILM NUMBER: 211060203
BUSINESS ADDRESS:
STREET 1: 1119 ST PAUL STREET
CITY: BALTIMORE
STATE: MD
ZIP: 21202
BUSINESS PHONE: 4102440115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVRx, Inc.
CENTRAL INDEX KEY: 0001235912
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 9201 WEST BROADWAY AVENUE
STREET 2: SUITE 650
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55445
BUSINESS PHONE: 7634162850
MAIL ADDRESS:
STREET 1: 9201 WEST BROADWAY AVENUE
STREET 2: SUITE 650
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55445
FORMER COMPANY:
FORMER CONFORMED NAME: CVRX INC
DATE OF NAME CHANGE: 20030527
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-06-29
0
0001235912
CVRx, Inc.
CVRX
0001132326
NEW ENTERPRISE ASSOCIATES 10 L P
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD
21093
0
0
1
0
Series A-2 Preferred Stock
Common Stock
58175
D
Series B-2 Preferred Stock
Common Stock
57241
D
Series C-2 Preferred Stock
Common Stock
71077
D
Series D-2 Preferred Stock
Common Stock
80178
D
Series E-2 Preferred Stock
Common Stock
83396
D
Series F-2 Preferred Stock
Common Stock
253605
D
Series G Preferred Stock
Common Stock
1196911
D
Each share of preferred stock is convertible, at the option of the holder, into shares of common stock at the then-effective conversion ratio for no additional consideration and has no expiration date. The shares of preferred stock will automatically convert into shares of common stock at the then-appliable conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares) upon the closing of the Issuer's initial public offering. The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the common stock.
Shares of Series A-2 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock, Series D-2 Convertible Preferred Stock, Series E-2 Convertible Preferred Stock and F-2 Convertible Preferred Stock are convertible into shares of common stock at a rate of 1-for-0.025857287.
Shares of Series G Convertible Preferred Stock are convertible into shares of common stock at a rate of 1-for-0.0632143218.
/s/ Sasha Keough, attorney-in-fact
2021-06-29